Concepedia

W. Tong

WT

Statistics

Publications

6

Citations

531

H-Index

6

Active since

1995

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

W. Tong is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and molecular oncology.

Publications per year

1995–2013

6

Publications

6

Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia

S-Q Kuang, W. Tong, Hui Yang et al. · Leukemia · 2008 · 162 citations

, , +16

A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis

Alfonso Quintás‐Cardama, W. Tong, Hagop M. Kantarjian et al. · Leukemia · 2008 · 114 citations

, , +10

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies

Alfonso Quintás‐Cardama, W. Tong, Taghi Manshouri et al. · Leukemia · 2008 · 97 citations

, , +12

BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation

René Hennig, Tarek Osman, Iréne Esposito et al. · British Journal of Cancer · 2008 · 65 citations · Full text

, , +15

Phase I trial of high-dose tamoxifen as a modulator of drug resistance in combination with daunorubicin in patients with relapsed or refractory acute leukemia.

Ellin Berman, M. McBride, Stephanie N. Lin et al. · PubMed · 1995 · 51 citations

, , +15

1–5 of 6